response, sustained by efficient CD4+ T cell help, is also a key player in HIV control. In this 74 review, we highlight the recent works that uncovered a potent memory B cell response in EC, 75 and that demonstrated the capacity of EC's sera to perform multiple effector functions 76 possibly involved in HIV control. We also examine the mechanisms that could underlie the 77 development and persistence of HIV-specific memory B cells in EC, including the 78 preservation of CD4+ T follicular helper (Tfh) cell functions and the possibility of more 79 efficient antigen presentation. 80 81
Low Neutralizing antibody titers in EC 82
The role of the humoral response was initially neglected in the HIV control research field, as 83 several studies had shown that EC had low HIV neutralizing antibody (NAb) titers as 84 compared to viremic individuals [5] [6] [7] [8] [9] . In addition, EC with the lowest levels of HIV 85 replication, who remained undetectable even in high-sensitivity viral loads assays (≤1 copy 86 HIV RNA/mL), showed signs of low-intensity antibody responses, with fewer viral protein 87 bands on HIV western blots, lower NAb titers, and lower cross-neutralization breadth [10] . 88 Conversely, in viremic patients, the breadth of neutralization has been associated with higher 89 viral loads [8, 9, [11] [12] [13] [14] [15] , longer duration of viral exposure, and higher viral diversity [16] . In 90 127 This is not to say that EC are free of HIV replication. EC are more and more often treated 128 with cART, which decreases immune activation, slightly increases CD4+ T cell counts, 129 decreases ASC frequency, and further decreases the viral load in these already well-controlled 130 patients [26, 30, 31] . Simian models suggest that limited viral replication persists in the 131 germinal centers (GC) of lymphoid organs in untreated controller monkeys [32] . It is thus 132 conceivable that the persistence of HIV-specific memory B cells in EC depends on residual 133 viral replication in GC, at the very site of antibody response maturation. Interestingly, 134
residual HIV replication appears to drive a persisting low-grade inflammation in some EC and 135 to influence B cell fates. A specific inflammation profile, characterized by increased levels of 136 of infected CD4+ T cells show more efficient ADCC activity against these cells [78] . 256
Competition between different types of antibodies may also influence ADCC function [79] . We thank all the participants and investigators of the ANRS CO21 CODEX cohort. We 335 apologize to the authors whose valuable work could not be discussed due to length 336 constraints. 337
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